• Aspira Women's Health named Chairman John Fraser interim CEO effective June 17, 2026, replacing Michael Buhle.
• Fraser will also serve as principal executive officer while the company searches internal and external candidates for a permanent CEO.
• Buhle’s exit was not tied to any dispute over operations, policies, or practices; separation terms remain under discussion.
• Fraser co-founded Seamark Capital, where he serves as co-portfolio manager at the growth equities asset management adviser.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000047), on June 22, 2026, and is solely responsible for the information contained therein.